Cardiome Pharma (CRME) Jumps: Stock Gains 7.3% - Tale of the Tape - Aeolus Pharmaceuticals (OTC:AOLS)

Cardiome Pharma Corp. (CRME) was a big mover last session with its shares rising over 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has gained over 19% since June 13.

This biopharmaceutical company has seen no estimate revision in the last 30 days. However, the Zacks Consensus Estimate has moved lower over the same period. This implies trouble down the road. So make sure to keep an eye on this stock going forward to see if Friday's rally can last.

Heron Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.

Investors interested in the Med-Drugs industry may consider better-ranked stocks like Aeolus Pharmaceuticals Inc. (AOLS), Ariad Pharmaceuticals Inc. (ARIA) and Aerie Pharmaceuticals, Inc. (AERI). All the three stocks hold a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.

Click to get this free report

CARDIOME PHARMA (CRME): Free Stock Analysis Report

AEOLUS PHARMACT (AOLS): Get Free Report

AERIE PHARMACT (AERI): Get Free Report

ARIAD PHARMA (ARIA): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Market News and Data brought to you by Benzinga APIs